The current study provides clinical and genetic evidence, which extends the phenotypic spectrum of PRPF8-, PRPH2-, RP1-, and RPGR-associated disease, and the genotypic spectrum of LCA/EOSRD. This evidence concerns the gene RP1 and Leber congenital amaurosis.